NEU neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-179

  1. 5,946 Posts.
    lightbulb Created with Sketch. 396


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.01
Change
0.700(5.26%)
Mkt cap ! $1.730B
Open High Low Value Volume
$13.50 $14.04 $12.96 $4.075M 299.0K

Buyers (Bids)

No. Vol. Price($)
3 109 $14.00
 

Sellers (Offers)

Price($) Vol. No.
$14.01 41 2
View Market Depth
Last trade - 11.54am 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.